Cargando…
First report of co-morbidity of pantothenate kinase-associated neurodegeneration and three types of chronic hemolytic anemias
BACKGROUND: Pantothenate kinase-associated neurodegeneration (PKAN), sickle cell anemia, and thalassemia are autosomal recessive disorders that can cause iron deposition in tissues during childhood. PKAN is characterized by accumulation of iron in the basal ganglia causing progressive extrapyramidal...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680082/ https://www.ncbi.nlm.nih.gov/pubmed/26740874 http://dx.doi.org/10.1016/j.amsu.2015.10.015 |
_version_ | 1782405628931604480 |
---|---|
author | Talaat, Iman M. Kamal, Naglaa M. El Melegy, Ebtessam H.K. Alghamdi, Hamed A. Aljabri, Mohammed F. Abdallah, Enas A.A. Sarar, Mohammed Alshahrani, Mohamed A. |
author_facet | Talaat, Iman M. Kamal, Naglaa M. El Melegy, Ebtessam H.K. Alghamdi, Hamed A. Aljabri, Mohammed F. Abdallah, Enas A.A. Sarar, Mohammed Alshahrani, Mohamed A. |
author_sort | Talaat, Iman M. |
collection | PubMed |
description | BACKGROUND: Pantothenate kinase-associated neurodegeneration (PKAN), sickle cell anemia, and thalassemia are autosomal recessive disorders that can cause iron deposition in tissues during childhood. PKAN is characterized by accumulation of iron in the basal ganglia causing progressive extrapyramidal manifestations. Thalassemia and sickle cell disease can cause iron overload and deposition in tissues, including central nervous system. PRESENTATION OF CASE: we herein report the first report of comorbidity of PKAN, β-thalassemia-major, sickle cell and glucose-6-phosphate dehydrogenase deficiency (G6PD) anemias in a 9 years old Saudi female patient who presented with gait disturbance, speech difficulty, and progressive movement disorders of the neck, upper and lower limbs. CONCLUSION: Although extremely rare, β-thalassemia-major, sickle cell and G6PD anemias can be associated with PKAN. It is unknown whether this association is random or due to an unknown factor that may have caused several mutations. |
format | Online Article Text |
id | pubmed-4680082 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-46800822016-01-06 First report of co-morbidity of pantothenate kinase-associated neurodegeneration and three types of chronic hemolytic anemias Talaat, Iman M. Kamal, Naglaa M. El Melegy, Ebtessam H.K. Alghamdi, Hamed A. Aljabri, Mohammed F. Abdallah, Enas A.A. Sarar, Mohammed Alshahrani, Mohamed A. Ann Med Surg (Lond) Case Report BACKGROUND: Pantothenate kinase-associated neurodegeneration (PKAN), sickle cell anemia, and thalassemia are autosomal recessive disorders that can cause iron deposition in tissues during childhood. PKAN is characterized by accumulation of iron in the basal ganglia causing progressive extrapyramidal manifestations. Thalassemia and sickle cell disease can cause iron overload and deposition in tissues, including central nervous system. PRESENTATION OF CASE: we herein report the first report of comorbidity of PKAN, β-thalassemia-major, sickle cell and glucose-6-phosphate dehydrogenase deficiency (G6PD) anemias in a 9 years old Saudi female patient who presented with gait disturbance, speech difficulty, and progressive movement disorders of the neck, upper and lower limbs. CONCLUSION: Although extremely rare, β-thalassemia-major, sickle cell and G6PD anemias can be associated with PKAN. It is unknown whether this association is random or due to an unknown factor that may have caused several mutations. Elsevier 2015-11-10 /pmc/articles/PMC4680082/ /pubmed/26740874 http://dx.doi.org/10.1016/j.amsu.2015.10.015 Text en © 2015 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Talaat, Iman M. Kamal, Naglaa M. El Melegy, Ebtessam H.K. Alghamdi, Hamed A. Aljabri, Mohammed F. Abdallah, Enas A.A. Sarar, Mohammed Alshahrani, Mohamed A. First report of co-morbidity of pantothenate kinase-associated neurodegeneration and three types of chronic hemolytic anemias |
title | First report of co-morbidity of pantothenate kinase-associated neurodegeneration and three types of chronic hemolytic anemias |
title_full | First report of co-morbidity of pantothenate kinase-associated neurodegeneration and three types of chronic hemolytic anemias |
title_fullStr | First report of co-morbidity of pantothenate kinase-associated neurodegeneration and three types of chronic hemolytic anemias |
title_full_unstemmed | First report of co-morbidity of pantothenate kinase-associated neurodegeneration and three types of chronic hemolytic anemias |
title_short | First report of co-morbidity of pantothenate kinase-associated neurodegeneration and three types of chronic hemolytic anemias |
title_sort | first report of co-morbidity of pantothenate kinase-associated neurodegeneration and three types of chronic hemolytic anemias |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680082/ https://www.ncbi.nlm.nih.gov/pubmed/26740874 http://dx.doi.org/10.1016/j.amsu.2015.10.015 |
work_keys_str_mv | AT talaatimanm firstreportofcomorbidityofpantothenatekinaseassociatedneurodegenerationandthreetypesofchronichemolyticanemias AT kamalnaglaam firstreportofcomorbidityofpantothenatekinaseassociatedneurodegenerationandthreetypesofchronichemolyticanemias AT elmelegyebtessamhk firstreportofcomorbidityofpantothenatekinaseassociatedneurodegenerationandthreetypesofchronichemolyticanemias AT alghamdihameda firstreportofcomorbidityofpantothenatekinaseassociatedneurodegenerationandthreetypesofchronichemolyticanemias AT aljabrimohammedf firstreportofcomorbidityofpantothenatekinaseassociatedneurodegenerationandthreetypesofchronichemolyticanemias AT abdallahenasaa firstreportofcomorbidityofpantothenatekinaseassociatedneurodegenerationandthreetypesofchronichemolyticanemias AT sararmohammed firstreportofcomorbidityofpantothenatekinaseassociatedneurodegenerationandthreetypesofchronichemolyticanemias AT alshahranimohameda firstreportofcomorbidityofpantothenatekinaseassociatedneurodegenerationandthreetypesofchronichemolyticanemias |